{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:00Z","timestamp":1791295260675,"version":"4.1.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"abstract":"<jats:p>Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM), 5 with monoclonal gammopathy of undetermined significance (MGUS), and 31 healthy volunteers (normal PCs) were purified by CD138+ selection. Gene expression of purified PCs and 7 MM cell lines were profiled using high-density oligonucleotide microarrays interrogating about 6800 genes. On hierarchical clustering analysis, normal and MM PCs were differentiated and 4 distinct subgroups of MM (MM1, MM2, MM3, and MM4) were identified. The expression pattern of MM1 was similar to normal PCs and MGUS, whereas MM4 was similar to MM cell lines. Clinical parameters linked to poor prognosis, abnormal karyotype (P\u2009=\u2009.002) and high serum \u03b22-microglobulin levels (P\u2009=\u2009.0005), were most prevalent in MM4. Also, genes involved in DNA metabolism and cell cycle control were overexpressed in a comparison of MM1 and MM4. In addition, using \u03c72 and Wilcoxon rank sum tests, 120 novel candidate disease genes were identified that discriminate normal and malignant PCs (P\u2009&amp;lt;\u2009.0001); many are involved in adhesion, apoptosis, cell cycle, drug resistance, growth arrest, oncogenesis, signaling, and transcription. A total of 156 genes, including FGFR3 andCCND1, exhibited highly elevated (\u201cspiked\u201d) expression in at least 4 of the 74 MM cases (range, 4-25 spikes). Elevated expression of these 2 genes was caused by the translocation t(4;14)(p16;q32) or t(11;14)(q13;q32). Thus, novel candidate MM disease genes have been identified using gene expression profiling and this profiling has led to the development of a gene-based classification system for MM.<\/jats:p>","DOI":"10.1182\/blood.v99.5.1745","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:40Z","timestamp":1027774000000},"page":"1745-1757","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":526,"title":["Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells"],"prefix":"10.1182","volume":"99","author":[{"given":"Fenghuang","family":"Zhan","sequence":"first","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Hardin","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Kordsmeier","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bumm","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhong","family":"Zheng","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erming","family":"Tian","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Sanderson","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Wilson","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zangari","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Anaissie","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morris","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Muwalla","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"van Rhee","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Fassas","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Crowley","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Tricot","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"From the Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, or Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, and the Southwest Oncology Group, Fred Hutchinson Cancer Research Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218224760100_B1","first-page":"1279","volume-title":"Plasma cell myeloma. In Beutler E, Lichtman M, Coller B, Kipps T, Seligsohn U, eds. Williams Hematology.","author":"Barlogie","year":"2001","edition":"6th ed."},{"key":"2020021218224760100_B2","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.","volume":"55","author":"Drach","year":"1995","journal-title":"Cancer Res."},{"key":"2020021218224760100_B3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V59.1.43.43","article-title":"Ploidy and proliferative characteristics in monoclonal gammopathies.","volume":"59","author":"Latreille","year":"1982","journal-title":"Blood."},{"key":"2020021218224760100_B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic findings in 200 patients with multiple myeloma.","volume":"82","author":"Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet."},{"key":"2020021218224760100_B5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood."},{"key":"2020021218224760100_B6","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.","volume":"86","author":"Tricot","year":"1995","journal-title":"Blood."},{"key":"2020021218224760100_B7","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","article-title":"Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.","volume":"95","author":"Desikan","year":"2000","journal-title":"Blood."},{"key":"2020021218224760100_B8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.1998.00657.x","article-title":"Prognostic value of cytogenetics in multiple myeloma.","volume":"101","author":"Seong","year":"1998","journal-title":"Br J Haematol."},{"key":"2020021218224760100_B9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V72.1.219.219","article-title":"Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.","volume":"72","author":"Greipp","year":"1988","journal-title":"Blood."},{"key":"2020021218224760100_B10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","article-title":"C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.","volume":"80","author":"Bataille","year":"1992","journal-title":"Blood."},{"key":"2020021218224760100_B11","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood.V81.12.3382.3382","article-title":"Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.","volume":"81","author":"Greipp","year":"1993","journal-title":"Blood."},{"key":"2020021218224760100_B12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH.","volume":"96","author":"Shaughnessy","year":"2000","journal-title":"Blood."},{"key":"2020021218224760100_B13","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood."},{"key":"2020021218224760100_B14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood.V97.6.1566","article-title":"Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy.","volume":"97","author":"Facon","year":"2001","journal-title":"Blood."},{"key":"2020021218224760100_B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/4447","article-title":"High density synthetic oligonucleotide arrays.","volume":"21","author":"Lipshutz","year":"1999","journal-title":"Nat Genet."},{"key":"2020021218224760100_B16","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns.","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood.V91.1.173","article-title":"Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27\/CD70 interaction.","volume":"91","author":"Agematsu","year":"1998","journal-title":"Blood."},{"key":"2020021218224760100_B18","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1073\/pnas.94.12.6346","article-title":"CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.","volume":"94","author":"Prasad","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B19","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.4049\/jimmunol.165.12.6809","article-title":"Ligation of CD27 on murine B cells responding to T-dependent and T-independent stimuli inhibits the generation of plasma cells.","volume":"165","author":"Raman","year":"2000","journal-title":"J Immunol."},{"key":"2020021218224760100_B20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.1061075","article-title":"Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation.","volume":"293","author":"Devireddy","year":"2001","journal-title":"Science."},{"key":"2020021218224760100_B21","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V88.10.3998.bloodjournal88103998","article-title":"Hepatocyte growth factor and its receptor c-met in multiple myeloma.","volume":"88","author":"Borset","year":"1996","journal-title":"Blood."},{"key":"2020021218224760100_B22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet."},{"key":"2020021218224760100_B23","first-page":"34","article-title":"Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival.","volume":"5","author":"Bathe","year":"1999","journal-title":"Cancer J Sci Am."},{"key":"2020021218224760100_B24","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1091\/mbc.9.10.2917","article-title":"A mutation in a novel yeast proteasomal gene, RPN11\/MPR1, produces a cell cycle arrest, overreplication of nuclear and mitochondrial DNA, and an altered mitochondrial morphology.","volume":"9","author":"Rinaldi","year":"1998","journal-title":"Mol Biol Cell."},{"key":"2020021218224760100_B25","doi-asserted-by":"crossref","first-page":"30470","DOI":"10.1074\/jbc.272.48.30470","article-title":"Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit.","volume":"272","author":"Spataro","year":"1997","journal-title":"J Biol Chem."},{"key":"2020021218224760100_B26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood.V91.3.1029","article-title":"Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma.","volume":"91","author":"Raaijmakers","year":"1998","journal-title":"Blood."},{"key":"2020021218224760100_B27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/nar\/28.5.1145","article-title":"Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein.","volume":"28","author":"Li","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"2020021218224760100_B28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/geno.1996.0540","article-title":"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.","volume":"37","author":"Shen","year":"1996","journal-title":"Genomics."},{"key":"2020021218224760100_B29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/geno.1996.0462","article-title":"UBL1, a human ubiquitin-like protein associating with human RAD51\/RAD52 proteins.","volume":"36","author":"Shen","year":"1996","journal-title":"Genomics."},{"key":"2020021218224760100_B30","first-page":"1161","article-title":"Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene\/pseudogenes.","volume":"46","author":"Chen","year":"1998","journal-title":"Biochem Mol Biol Int."},{"key":"2020021218224760100_B31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process.","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood."},{"key":"2020021218224760100_B32","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells.","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science."},{"key":"2020021218224760100_B33","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1126\/science.277.5334.1948","article-title":"Tying it all together: epigenetics, genetics, cell cycle, and cancer.","volume":"277","author":"Baylin","year":"1997","journal-title":"Science."},{"key":"2020021218224760100_B34","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1182\/blood.V89.7.2500","article-title":"Frequent hypermethylation of p16 and p15 genes in multiple myeloma.","volume":"89","author":"Ng","year":"1997","journal-title":"Blood."},{"key":"2020021218224760100_B35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.leu.2401617","article-title":"De novo methylation of tumor suppressor gene p16\/INK4a is a frequent finding in multiple myeloma patients at diagnosis.","volume":"14","author":"Gonzalez","year":"2000","journal-title":"Leukemia."},{"key":"2020021218224760100_B36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","article-title":"Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.","volume":"97","author":"Mizuno","year":"2001","journal-title":"Blood."},{"key":"2020021218224760100_B37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/71750","article-title":"DNA methyltransferase Dnmt1 associates with histone deacetylase activity.","volume":"24","author":"Fuks","year":"2000","journal-title":"Nat Genet."},{"key":"2020021218224760100_B38","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1016\/S0021-9258(17)31603-4","article-title":"A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses.","volume":"269","author":"Toh","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021218224760100_B39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1097-2765(00)80299-3","article-title":"NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.","volume":"2","author":"Xue","year":"1998","journal-title":"Mol Cell."},{"key":"2020021218224760100_B40","first-page":"811","article-title":"A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.","volume":"7","author":"Largaespada","year":"1992","journal-title":"Oncogene."},{"key":"2020021218224760100_B41","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0889-8588(18)30340-X","article-title":"Perspectives on the origins of multiple myeloma and plasmacytomas in mice.","volume":"6","author":"Potter","year":"1992","journal-title":"Hematol Oncol Clin North Am."},{"key":"2020021218224760100_B43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.","volume":"97","author":"Shou","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B44","first-page":"277","article-title":"Dysregulation of c-myc in multiple myeloma.","volume":"224","author":"Kuehl","year":"1997","journal-title":"Curr Top Microbiol Immunol."},{"key":"2020021218224760100_B45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0996-25","article-title":"The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.","volume":"14","author":"Stickens","year":"1996","journal-title":"Nat Genet."},{"key":"2020021218224760100_B46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/514","article-title":"The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.","volume":"19","author":"McCormick","year":"1998","journal-title":"Nat Genet."},{"key":"2020021218224760100_B47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1073\/pnas.97.2.668","article-title":"The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.","volume":"97","author":"McCormick","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","article-title":"Serum syndecan-1: a new independent prognostic marker in multiple myeloma.","volume":"95","author":"Seidel","year":"2000","journal-title":"Blood."},{"key":"2020021218224760100_B49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/77108","article-title":"Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.","volume":"25","author":"Alexander","year":"2000","journal-title":"Nat Genet."},{"key":"2020021218224760100_B50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)81921-2","article-title":"Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer.","volume":"88","author":"Leyns","year":"1997","journal-title":"Cell."},{"key":"2020021218224760100_B51","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.94.7.2859","article-title":"A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.","volume":"94","author":"Rattner","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021218224760100_B52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)00004-2","article-title":"Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism.","volume":"13","author":"Reya","year":"2000","journal-title":"Immunity."},{"key":"2020021218224760100_B53","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood.V92.9.3189","article-title":"Role of members of the Wnt gene family in human hematopoiesis.","volume":"92","author":"Van Den Berg","year":"1998","journal-title":"Blood."},{"key":"2020021218224760100_B54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.","volume":"286","author":"Golub","year":"1999","journal-title":"Science."},{"key":"2020021218224760100_B55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/5\/1745\/1680829\/h8050201745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/5\/1745\/1680829\/h8050201745.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:12:51Z","timestamp":1622020371000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/5\/1745\/106910\/Global-gene-expression-profiling-of-multiple"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.5.1745","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}